The U.S. spends nearly $27 billion each year treating vaccine-preventable diseases. At a time when measles outbreaks are surging, tuberculosis cases are climbing, childhood vaccination rates are plummeting, and families…
Highlights from the Vaccine Equity and Access Program 2021-2025
Leveraging Community Catalyst's VEAP Model to Strengthen Community-Based Organization Engagement in Public Health
As part of Community Catalyst’s Community-first Public Health initiative, we leveraged trusted relationships with our Vaccine Equity and Access Program (VEAP) partners to understand the physical, mental and economic impacts…
As members of Community Catalyst’s Vaccine Equity and Access Program (VEAP), a vital component to our collective success includes sharing and gathering community insights from one another. While challenges to…
The Vaccine Equity and Access Program created a comprehensive communications toolkit to help community-based organizations share accurate and relevant information about COVID-19 and flu vaccines with their communities.
In 2020, CDC launched the Partnering for Vaccine Equity (P4VE) program to advance equity in adult immunization for racial and ethnic minority groups through partnerships that drive community-level action. While…
In its first year, the Vaccine Equity & Access Program (VEAP) partnered with three other national organizations to protect communities, empower families, and stop myths.
Community Catalyst’s Vaccine Equity and Access Program (VEAP) increases equitable access to COVID-19 and influenza vaccines by supporting community-based organizations (CBOs) to engage communities of color, who are historically medically…
Community Catalyst’s Vaccine Equity Access Program (VEAP) works to address vaccine hesitancy and increase vaccination coverage among racial and ethnic populations experiencing disparities in the United States.